Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • squirrel24
    Junior Member
    • Oct 2012
    • 1

    #1

    Non-model polyploid plant Illumina RNA-seq: Paired/single ends? Fragment size range?

    I would like to obtain short-read Illumina HiSeq 2000 transcriptomic data (RNA-Seq) for individuals representing closely-related diploid and polyploid plant species. Our aim is to identify and analyze comparatively the putative orthologues, paralogues and homeologes involved in parallel allopolyploidization events. We also want to develop new phylogenetic markers for the genus from the transcriptomic data.

    I am new to transcriptomics (this is my first post ) and I want to make sure that we are doing the most appropriate sample prep for our study system and questions. Apoligies if my questions are naive!

    For our species of interest, which are diploid/polyploid plants, with large-ish genomes, and NO reference genome currently available, I had thought 2x100 paired end reads would be the best approach based on forum posts and discussions with colleagues. However one sequencing facility ("facility A") that I wrote to asking for a quote advised me to do 1x100 single end reads instead, because they said that their fragmentation step in the cDNA library prep produces average fragment sizes of 125-150bp, so paired end reads would not provide any additional information and would not be worth the extra cost. However, another sequencing facility ("facility B") that sent me a quote said they would generate fragments ranging from 125-450 for paired end sequencing.

    So, which is the best approach? My two main quesitons at this stage are, 1) should we do single end 1x100 or paired end 2x100 reads? and 2) what is the ideal fragment size (or fragment size range) we should be using? In theory wouldn't it provide more information (and make the downstream bioinformatics easier) to generate paired end reads from a larger range of fragment sizes (i.e. facility B's quote), rather than generate single end reads on a smaller range of fragment sizes (i.e. facility A's advice)? Or are there tradeoffs with respect to using larger fragment sizes or a larger RANGE of fragment sizes?

    I look forward to any suggestions people may have. Thanks in advance.
  • luc
    Senior Member
    • Dec 2010
    • 469

    #2
    Hi,

    If you are looking into transcriptome assembly, I would suggest the paired end reads. Your service should be able to adjust the fragment sizes to your needs - other wise you can generate the libraries yourself. Two different insert sizes might be helpful, in this case.

    For differential gene expression applications single end sequencing could indeed be sufficient.

    Comment

    • Jeremy
      Senior Member
      • Nov 2009
      • 190

      #3
      Paired end is definitely the way to go for de novo assembly. Personally I would look for a sequencing facility that can give data with less spread of fragment size, 125-450 is not great. My most recent data has a range of about 350-500 bp. The fragment size range depends on the shearing method and clean up.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
        by SEQadmin2




        NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
        Today, 06:46 AM
      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-28-2026, 09:57 AM
      0 responses
      24 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-28-2026, 09:51 AM
      0 responses
      15 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      68 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      48 views
      0 reactions
      Last Post SEQadmin2  
      Working...